FDA Finalizes Guidance On ‘Unique Challenges’ Of Psychedelic Research And Schedules Hearing On Therapeutic Uses

The Food and Drug Administration (FDA) has issued finalized guidance to help researchers studying the therapeutic benefits of psychedelics navigate the “unique challenges” of such investigations. The agency also announced it will be holding a public hearing on psychedelic therapy issues in September. “In recent years, interest in the therapeutic potential of psychedelic drugs has been increasing,” the FDA document published on Monday says. “Drug development programs for psychedelic drugs are subject to the same…